Malayalam poet and lyricist Anil Panachooran passed away after suffering a cardiac arrest while undergoing treatment for COVID-19 at a hospital in Thiruvananthapuram today, reports ANI.
Jagannath temple reopens for all devotees, reports PTI.
At 3, Mumbai reports lowest Covid-19 deaths since March last year, reports PTI.
UK-strain is a whole virus...India-made vaccines target all the proteins on the surface of the virus, not just one S-GEN protein that has mutated. Therefore those vaccines that are targeting just the 'SGEN' may not work as well. But that is still scientific conjecture.
Bharat Biotech has been asked to submit updated safety, efficacy & immunogenicity data from the ongoing Phase I, II & Ill clinical trials till the completion of trials.
Drugs Controller General of India (DCGI) gives licensing permission to Bharat Biotech to manufacture Covaxin.
Tracing the spread of Covid-19
Serum Institute says to meet local demand for AstraZeneca vaccine for next two months, before exporting, reports Reuters.
What we know is that we've been able to control the pandemic in the country by following Covid appropriate behaviour.
We don't know how long vaccine is going to effective, we don't know how much of the population we will have to vaccinate to break the virus transmission.
We hope potentially Bharat Biotech vaccine will have some advantages over other vaccines on this new strain because it is a whole virus: Dr Balram Bhargava, DG ICMR
NIV scientists have successfully isolated the new virus strain and this will be tested against different vaccines: Dr Balram Bhargava, DG ICMR
There are 29 patients in India with the same variant for which we should be cautious. We have been able to isolate the new virus very soon.
New virus variant which is now more than 60% infective & creating havoc in the UK is worrisome.
MP govt orders closure of Covid centres; Congress questions logic, reports PTI.
Badminton world number one Kento Momota tested positive for coronavirus on Sunday, prompting the withdrawal of all Japan's players from this month's Thailand Open, reports AFP.
Delhi records 424 new Covid-19 cases, lowest in over seven months; death toll 10,585 with 14 more fatalities, reports PTI.
Read: Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
ICMR and Bharat Biotech collaborative a whole Virion Inactivated Corona Virus Vaccine (Covaxin) is being approved for restricted use in an emergency by Drugs Controller General of India (DCGI): ICMR
Initially, the Serum Institute vaccine will be given. They already have 50 million doses available and they'll be able to give that in an initial phase where we'll vaccinate around 3 crore people. Gradually, we'll build on it and by the time Bharat Biotech data will also be available.
69 More Updates
See More Updates